Active substanceZinc oxideZinc oxide
Similar drugsTo uncover
  • Tsindol
    suspension externally 
  • Tsindol
    suspension externally 
  • Tsindol
    suspension externally 
  • Tsindol
    suspension externally 
  • Tsindol
    suspension externally 
    YUZHFARM, LLC     Russia
  • Zinc ointment
    ointment externally 
  • Zinc ointment
    ointment externally 
  • Zinc ointment
    ointment externally 
  • Zinc ointment
    ointment externally 
    SYNTHESIS, OJSC     Russia
  • Zinc ointment
    ointment externally 
    SAMARAHEDPROM, JSC     Russia
  • Zinc ointment
    ointment externally 
  • Zinc ointment
    ointment externally 
    BIOSINTEZ, PAO     Russia
  • Zinc ointment
    ointment externally 
  • Zinc paste
    paste externally 
  • Zinc paste
    paste externally 
  • Zinc paste
    paste externally 
  • Dosage form: & nbsp

    Suspension for external use.

    Composition:

    Composition per 100 g

    Active substance:

    Zinc oxide (Zinc oxide) - 12.5 g Excipients: Talc - 12.5 g, Starch potato variety "Extra" or "Higher" - 12.5 g, Glycerol (20 g), Ethanol (Ethyl alcohol) 70% - 20.0 g, Purified water up to 100 , 0 g.

    Description:

    Inhomogeneous suspension with a rapidly precipitated white or white precipitate after shaking, with a grayish hue of color.

    Pharmacotherapeutic group:Dermatoprotective agent.
    ATX: & nbsp

    A.12.C.B   Zinc Preparations

    Pharmacodynamics:

    Antiseptic, astringent, drying agent. Reduces exudation and mocclusion, which removes local inflammation and irritation. The symptomatic effect of the drug is determined by zinc oxide.

    Indications:

    Dermatitis, skin ulcers, intertrigo.

    Contraindications:

    Hypersensitivity to the components of the drug.

    Pregnancy and lactation:

    Possible use during pregnancy and during breastfeeding.

    Dosing and Administration:

    Outwardly. Shake before use. Tampon moistened with the drug, apply a suspension on the affected skin 2-3 times a day.

    Side effects:

    Possible local allergic reactions: itching, hyperemia, rash.

    If any of the side effects listed in the manual are aggravated, or if you notice other side effects not listed in the instructions, tell your doctor.

    Overdose:

    To date, cases of overdose have not been reported.

    Interaction:

    Not described.

    Special instructions:

    Avoid contact with eyes.

    Effect on the ability to drive transp. cf. and fur:

    The use of the drug does not affect the management of vehicles and the employment of other potentially hazardous activities requiring increased concentration of attention and speed of psychomotor reactions.

    Form release / dosage:

    Suspension for external use 12,5%.

    Packaging:

    100 g or 125 g in bottles of orange glass with a screw neck or in glass bottles made of brown glass with a screw neck, sealed with polymer caps and polymer screw caps or plastic caps with or without plugs, or aluminum caps with perforations. Each bottle, together with the instructions for use, is placed in a pack of cardboard.

    Packing for hospitals.

    Vials of 100 g or 125 g, together with an equal number of instructions for use, are placed in a group package forhospitals for 28 pcs. or 32 pcs.

    Storage conditions:

    In dry, the dark place at a temperature of no higher than 25 C.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use the drug after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-001738/10
    Date of registration:05.03.2010
    The owner of the registration certificate:MOSCOW PHARMACEUTICAL FACTORY, CJSC MOSCOW PHARMACEUTICAL FACTORY, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp09.10.2015
    Illustrated instructions
      Instructions
      Up